Nautilus Biotechnology Inc (NAUT)
2.69
+0.02
(+0.75%)
USD |
NASDAQ |
May 03, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology 1 Year Total Returns (Daily): 21.72% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 21.72% |
| May 02, 2024 | 17.62% |
| May 01, 2024 | 9.45% |
| April 30, 2024 | -1.55% |
| April 29, 2024 | -0.39% |
| April 26, 2024 | 2.05% |
| April 25, 2024 | -4.45% |
| April 24, 2024 | -6.98% |
| April 23, 2024 | -1.19% |
| April 22, 2024 | -3.97% |
| April 19, 2024 | -6.11% |
| April 18, 2024 | -10.69% |
| April 17, 2024 | -13.21% |
| April 16, 2024 | -10.95% |
| April 15, 2024 | -13.07% |
| April 12, 2024 | -10.51% |
| April 11, 2024 | -5.05% |
| April 10, 2024 | -5.88% |
| April 09, 2024 | 0.00% |
| April 08, 2024 | 2.66% |
| April 05, 2024 | 1.52% |
| April 04, 2024 | -1.12% |
| April 03, 2024 | 0.73% |
| April 02, 2024 | -2.17% |
| April 01, 2024 | 8.30% |
| Date | Value |
|---|---|
| March 28, 2024 | 9.70% |
| March 27, 2024 | 10.36% |
| March 26, 2024 | 3.98% |
| March 25, 2024 | 5.58% |
| March 22, 2024 | 6.85% |
| March 21, 2024 | 4.55% |
| March 20, 2024 | 18.70% |
| March 19, 2024 | 15.04% |
| March 18, 2024 | 15.93% |
| March 15, 2024 | 15.84% |
| March 14, 2024 | 13.64% |
| March 13, 2024 | 30.05% |
| March 12, 2024 | 14.41% |
| March 11, 2024 | 8.56% |
| March 08, 2024 | 35.45% |
| March 07, 2024 | 31.84% |
| March 06, 2024 | 24.65% |
| March 05, 2024 | 19.18% |
| March 04, 2024 | 22.83% |
| March 01, 2024 | 26.51% |
| February 29, 2024 | 26.89% |
| February 28, 2024 | 32.08% |
| February 27, 2024 | 47.00% |
| February 26, 2024 | 51.96% |
| February 23, 2024 | 51.08% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.85%
Minimum
Feb 08 2022
104.2%
Maximum
Dec 27 2023
-25.66%
Average
-45.41%
Median
Feb 16 2023
1 Year Total Returns (Daily) Benchmarks
| Amicus Therapeutics Inc | -13.76% |
| Geron Corp | 47.19% |
| TG Therapeutics Inc | -53.57% |
| Editas Medicine Inc | -32.18% |
| G1 Therapeutics Inc | 48.68% |